US Stock MarketDetailed Quotes

SLXNW BIOMOTION SCIENCES C/WTS EXP 14/08/2029 (TO PUR COM)

Watchlist
  • 0.096
  • +0.026+36.95%
Close Aug 23 16:00 ET
0Market Cap0.00P/E (TTM)

About BIOMOTION SCIENCES C/WTS EXP 14/08/2029 (TO PUR COM) Company

Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.

Company Profile

SymbolSLXNW
Company NameBIOMOTION SCIENCES C/WTS EXP 14/08/2029 (TO PUR COM)
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Address2 Ha'mayan Street
CityModiin
ProvinceJerusalem
CountryIsrael
Zip Code7177871
Phone972-8-628-6005
Websitehttps://www.silexion.com

Company Executives

  • Name
  • Position
  • Salary
  • Ilan Hadar
  • Chairman of the Board and Prospective Chief Executive Officer
  • 253.61K
  • Mirit Horenshtein Hadar
  • Executive Vice President, Finance Affairs and Prospective Chief Financial Officer
  • 26.24K
  • Dr. Mitchell Shirvan
  • Chief Scientific and Development Officer
  • 206.80K
  • Ilan Levin
  • Independent Director
  • --
  • Dror J. Abramov
  • Independent Director
  • --
  • Avner Lushi
  • Independent Director
  • --
  • Shlomo Noy
  • Independent Director
  • --
  • Ilan Shiloah
  • Independent Director
  • --
  • Ruth Alon
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg